Oracle Corporation vs Synopsys, Inc.: Strategic Focus on R&D Spending

Oracle vs Synopsys: R&D Spending Trends Over a Decade

__timestampOracle CorporationSynopsys, Inc.
Wednesday, January 1, 20146175000000718768000
Thursday, January 1, 20155524000000776229000
Friday, January 1, 20166346000000856705000
Sunday, January 1, 20176153000000908841000
Monday, January 1, 201860840000001084822000
Tuesday, January 1, 201960260000001136932000
Wednesday, January 1, 202060670000001279022000
Friday, January 1, 202165270000001504823000
Saturday, January 1, 202276940000001680379000
Sunday, January 1, 202394150000001946813000
Monday, January 1, 202489150000002082360000
Loading chart...

Unlocking the unknown

Oracle vs Synopsys: A Decade of R&D Investment

In the ever-evolving tech landscape, strategic investment in research and development (R&D) is crucial for maintaining a competitive edge. Over the past decade, Oracle Corporation and Synopsys, Inc. have demonstrated distinct approaches to R&D spending. Oracle's R&D expenses have surged by approximately 44% from 2014 to 2023, peaking in 2023 with a notable increase of 22% from the previous year. This reflects Oracle's commitment to innovation and adaptation in a rapidly changing market.

Conversely, Synopsys, Inc. has consistently increased its R&D investment, with a remarkable 190% growth over the same period. This steady rise underscores Synopsys's focus on enhancing its technological capabilities and expanding its market reach. As we look to 2024, both companies continue to prioritize R&D, signaling their dedication to future growth and technological advancement.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
28 Jan 2025